A growing number of studies involve the role of prone positioning to improve ventilation in patients with acute respiratory distress syndrome (ARDS) related to COVID-19.
In part 2 of this 3-part series, the recent State of Lung Cancer report by the American Lung Association, which included state-level and national-level data on lung cancer in people of color for the first time.
Investigators studied the reactivation of cytomegalovirus in critically ill patients with sepsis and identified measured of CMV reactivation that were associated with worse clinical outcomes.
By broadly defining respiratory failure to include an increase in oxygen requirements, a conservative initial IV fluids resuscitation strategy did not correlate with decreased rates of hypoxemic respiratory failure in sepsis.
Study authors assessed the association of piperacillin/tazobactam MIC, meropenem MIC, and beta-lactam resistance genes with mortality in the MERINO trial.
The effects of positive end expiratory pressure in COVID-19-related acute respiratory distress syndrome (ARDS) are similar to those reported in classical ARDS.
Treatment with beta-blockers vs amiodarone, calcium channel blockers, or digoxin was associated with improved heart control at 1, but not 6 hours in patients with sepsis and atrial fibrillation.
In patients with acute respiratory distress syndrome (ARDS) receiving venovenous extracorporeal oxygenation (ECMO), the use of prone positioning improved oxygenation and was associated with reduced rates of hospital mortality.
